Navigation Links
GenVec Reports Second Quarter 2011 Financial Results
Date:8/9/2011

GAITHERSBURG, Md., Aug. 9, 2011 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced its financial results for the three months and six months ended June 30, 2011.  

"During the second quarter we made significant progress in key programs including our collaboration with Novartis to develop treatments for hearing loss and balance disorders," said Dr. Paul Fischer, President and Chief Executive Officer. "We enter the second half of 2011 with strong momentum and look ahead to achieving key objectives in this collaboration as well as in our vaccine programs including foot-and-mouth disease and respiratory syncytial virus."

Recent Events

  • In April, research was published describing how GenVec technology, utilizing a vector targeted to supporting cells and limited in expression to those cells, can be used to restore balance function in an animal model.
  • In May, we expanded our relationship with Merial, the animal health division of sanofi-aventis, to include the evaluation of our technology for use against swine diseases.
  • In May, we regained compliance with NASDAQ listing requirements.
  • At the Company's annual meeting in June, Adel A.F. Mahmoud, M.D., Ph.D. and Edward M. Connor, Jr., M.D. were elected to the Company's Board of Directors adding to the Board's expertise in the areas of infectious disease and vaccine development.

  • Financial Results for the Three and Six Months Ended June 30, 2011GenVec reported a net loss of $1.2 million ($0.10 per share) for the three months ended June 30, 2011 compared to a net loss of $4.2 million ($0.33 per share) in the comparable quarter of 2010. For the six months ended June 30, 2011, GenVec's net loss was $3.5 million ($0.27 per share) compared to a net loss of $8.9 million ($0.72 per share) for the six months ended June 30, 2010.  

    Revenues for the three-month an
    '/>"/>

    SOURCE GenVec, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. GenVec Elects Adel A.F. Mahmoud and Edward M. Connor, Jr. to Board of Directors
    2. GenVec to Host First Quarter 2011 Earnings Call and Webcast
    3. GenVec Reports Fourth Quarter and 2010 Year-End Financial Results
    4. GenVec Forms Collaboration With World-Leading Animal Health Company
    5. GenVec Reports Third Quarter 2010 Financial Results
    6. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
    7. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
    8. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
    9. Providence Service Corporation Reports Q2 2011 Results In Line With Expectations
    10. Pharmos Corporation Reports 2011 Second Quarter Results
    11. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/3/2015)... August 3, 2015 BiondVax Pharmaceuticals Ltd. ... analysis of results from a study which demonstrates that BiondVax,s ... trial which took place in 2012, provided participants with increased ... time of the study- in particular the current newly emerged ... the United States in 2015. ...
    (Date:8/3/2015)... SAN DIEGO , Aug. 3, 2015  Sorrento ... that it has entered into an exclusive licensing agreement ... or biobetter antibodies from Mabtech Limited, a holding company ... China . Under the ... these 4 monoclonal antibodies (mAbs) for the North American, ...
    (Date:7/31/2015)... July 31, 2015  Physicians and payers alone ... biopharmaceutical market. Patients are better informed and getting ... switching therapies. This shift in power is reshaping ... toward patient-focused marketing. As part of ... learned it,s important to educate, communicate and engage ...
    Breaking Medicine Technology:Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 2Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 3Sorrento In-Licenses Four Late-Stage Clinical Biobetter and Biosimilar Antibodies 4Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2
    ... N.J., July 11, 2011 MonoSol Rx, a ... PharmFilm® technology platform, in collaboration with APR Applied ... that its FDA-approved anti-emetic Zuplenz (Ondansetron) oral soluble ... partners.  The Company made the strategic decision to ...
    ... YORK, July 11, 2011 Reportlinker.com announces ... available in its catalogue: ... approval brings lessons and hope to market ... To order this report: ...
    Cached Medicine Technology:MonoSol Rx Announces Availability of Zuplenz® Oral Soluble Film for Licensing to New Commercialization Partners 2MonoSol Rx Announces Availability of Zuplenz® Oral Soluble Film for Licensing to New Commercialization Partners 3
    (Date:8/3/2015)... ... , ... The art of preparing and cooking food comes naturally to some. ... age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that she is ... Persian Kitchen with the world. , Since Americans tend to be undereducated about Persian ...
    (Date:8/3/2015)... , ... August 03, 2015 , ... ... National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its least visited ... untapped ground water aquifers, whose main outflow is at Ahjumawi Lava Springs, part ...
    (Date:8/3/2015)... ... August 03, 2015 , ... From ... by 39 percent, according to market research compiled for the National Association of ... U.S. Department of Labor, Bureau of Labor Statistics. As the number of dental ...
    (Date:8/3/2015)... ... August 03, 2015 , ... Constantin Vasilica, 48 from Romania ... injury caused by diabetes after many years of suffering and using medications with strong ... didn’t want to ask for extra time off or wait longer hours in the ...
    (Date:8/3/2015)... ... 03, 2015 , ... The American Institute of Architects ... to collaborate across a wide range of initiatives ranging from code development and ... , “Our combined membership, consisting of practicing design professionals, code officials, and the ...
    Breaking Medicine News(10 mins):Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 2Health News:Architects, International Code Council Ink Five-Year Collaborative Agreement 3
    ... fruit fly,s immune system can tell time, researchers at ... how hard it punches back against infections depends on ... could have implications for human health, too. , Working ... cycle and with syringes small enough to inject measured ...
    ... LLC will be featured in an upcoming episode. , ... Deerfield Beach, ... are pleased to announce that Gradient Medical, LLC will be featured in ... Tomorrow,s Health Solutions Today., , ,Pain is a national public healthcare crisis. ...
    ... of a breast cancer prevention study using exemestane (Aromasin) ... ongoing phase II study details reported today, by Jennifer ... Comprehensive Cancer Center at the San Antonio Breast Cancer ... who are at an increased risk of developing breast ...
    ... Expression of the microtubule-binding protein Tau is not a ... paclitaxel chemotherapy, according to research led by The University ... today, Dec. 13, at the CRTC-AACR San Antonio Breast ... predict survival, yet in an unexpected way. ...
    ... areas that show up light on a mammogram - ... "why" remains to be answered. Now, by examining dense ... volunteers, researchers from Mayo Clinic have found several potential ... poster form at the Cancer Therapy & Research Center-American ...
    ... the finish line in second place at the 2008 Ford Ironman ... for 34 year-old Jason Fowler, who was one of five wheelchair ... the Pacific Ocean, using only his arms, a 112-mile bike ride ... that Jason completed in a racing wheelchair in 90 degree heat. ...
    Cached Medicine News:Health News:Snoring or soaring? Strength of fruit-fly immune system varies 2Health News:Snoring or soaring? Strength of fruit-fly immune system varies 3Health News:"The Economic Report" Show to Feature Gradient Medical, LLC 2Health News:Tau protein expression predicts breast cancer survival -- though not as expected 2Health News:Tau protein expression predicts breast cancer survival -- though not as expected 3Health News:Mayo researchers find potential links between breast density and breast cancer risk 2Health News:Mayo researchers find potential links between breast density and breast cancer risk 3Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 2Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 3Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 4Health News:Video: Paralyzed From the Chest Down, Triathlete Takes Second in the Handcycle Division of the Ford Ironman World Championship 5
    ... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
    ... LMW Automated Microplate ... choice for any laboratory. ... sensor allows a precise ... residual volume, digitally controlled ...
    ... ELx50 is a fast and versatile automated strip ... manifold. It is a self contained and programmable ... fluidic delivery from the gentle dripping of a ... pressure delivery systems. ELx50/12V processes 1 x 12 ...
    ... The Microplate washer MP-1200 is ... microplate washing system. Its internal micropumps ... and to discharge from all types ... microplate to be washed in rows ...
    Medicine Products: